国产午夜福利片1000无码丨人妻国产成人久久av免费高清丨午夜做受视频试看6次丨日韩av不卡一区在线免费观看丨在线观看精品三级欧美

Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱 貨號 規(guī)格
Recombinant Meyerozyma guilliermondii Probable endonuclease LCL3 (LCL3), partial CSB-YP398525MTM1
CSB-EP398525MTM1
CSB-BP398525MTM1
CSB-MP398525MTM1
CSB-EP398525MTM1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Meyerozyma guilliermondii Elongation factor 1-alpha (TEF1) CSB-YP398526MTM
CSB-EP398526MTM
CSB-BP398526MTM
CSB-MP398526MTM
CSB-EP398526MTM-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Meyerozyma guilliermondii ATP-dependent rRNA helicase RRP3 (RRP3) CSB-YP398527MTM
CSB-EP398527MTM
CSB-BP398527MTM
CSB-MP398527MTM
CSB-EP398527MTM-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Meyerozyma guilliermondii ADP-ribose 1'-phosphate phosphatase (POA1) CSB-YP398528MTM
CSB-EP398528MTM
CSB-BP398528MTM
CSB-MP398528MTM
CSB-EP398528MTM-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Lodderomyces elongisporus ATPase synthesis protein 25, mitochondrial (ATP25), partial CSB-YP398529LLV
CSB-EP398529LLV
CSB-BP398529LLV
CSB-MP398529LLV
CSB-EP398529LLV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Lodderomyces elongisporus Protein transport protein SEC24 (SEC24), partial CSB-YP398530LLV
CSB-EP398530LLV
CSB-BP398530LLV
CSB-MP398530LLV
CSB-EP398530LLV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Lodderomyces elongisporus Protein FMP52, mitochondrial (FMP52) CSB-YP398531LLV
CSB-EP398531LLV
CSB-BP398531LLV
CSB-MP398531LLV
CSB-EP398531LLV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Lodderomyces elongisporus Assembly factor CBP4 (CBP4), partial CSB-YP398532LLV1
CSB-EP398532LLV1
CSB-BP398532LLV1
CSB-MP398532LLV1
CSB-EP398532LLV1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Lodderomyces elongisporus Altered inheritance of mitochondria protein 36, mitochondrial (AIM36), partial CSB-YP398533LLV1
CSB-EP398533LLV1
CSB-BP398533LLV1
CSB-MP398533LLV1
CSB-EP398533LLV1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Lodderomyces elongisporus Ribosome-releasing factor 2, mitochondrial (MEF2) CSB-YP398534LLV
CSB-EP398534LLV
CSB-BP398534LLV
CSB-MP398534LLV
CSB-EP398534LLV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Lodderomyces elongisporus ATP-dependent RNA helicase MAK5 (MAK5), partial CSB-YP398535LLV
CSB-EP398535LLV
CSB-BP398535LLV
CSB-MP398535LLV
CSB-EP398535LLV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Lodderomyces elongisporus Protein LOT5 (LOT5) CSB-YP398536LLV
CSB-EP398536LLV
CSB-BP398536LLV
CSB-MP398536LLV
CSB-EP398536LLV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Lodderomyces elongisporus ATP-dependent RNA helicase eIF4A (TIF1) CSB-YP398537LLV
CSB-EP398537LLV
CSB-BP398537LLV
CSB-MP398537LLV
CSB-EP398537LLV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Lodderomyces elongisporus Histone H3.1/H3.2 (HHT1) CSB-YP398538LLV
CSB-EP398538LLV
CSB-BP398538LLV
CSB-MP398538LLV
CSB-EP398538LLV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Lodderomyces elongisporus ATP-dependent RNA helicase FAL1 (FAL1) CSB-YP398539LLV
CSB-EP398539LLV
CSB-BP398539LLV
CSB-MP398539LLV
CSB-EP398539LLV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Lodderomyces elongisporus Chromosome segregation in meiosis protein 3 (CSM3) CSB-YP398540LLV
CSB-EP398540LLV
CSB-BP398540LLV
CSB-MP398540LLV
CSB-EP398540LLV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Lodderomyces elongisporus Ribosome biogenesis protein NSA1 (NSA1) CSB-YP398541LLV
CSB-EP398541LLV
CSB-BP398541LLV
CSB-MP398541LLV
CSB-EP398541LLV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Lodderomyces elongisporus Autophagy-related protein 27 (ATG27), partial CSB-YP398542LLV
CSB-EP398542LLV
CSB-BP398542LLV
CSB-MP398542LLV
CSB-EP398542LLV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Lodderomyces elongisporus 40S ribosomal protein S0 (RPS0) CSB-YP398543LLV
CSB-EP398543LLV
CSB-BP398543LLV
CSB-MP398543LLV
CSB-EP398543LLV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Lodderomyces elongisporus ATP-dependent RNA helicase DBP5 (DBP5), partial CSB-YP398544LLV
CSB-EP398544LLV
CSB-BP398544LLV
CSB-MP398544LLV
CSB-EP398544LLV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長度(全長或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時,你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗更有可能成功。但是如果你做了錯誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗總結(jié)出了幾個有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個有用的技巧來選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問題。您可以單擊以下鏈接查看。http://www.jhhuazhong.com/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對CUSABIO的蛋白質(zhì)有任何疑問,涉及到蛋白質(zhì)的價格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們在線留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>